FineMark National Bank & Trust’s Exelixis EXEL Stock Holding History

FineMark National Bank & Trust’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,000	Closed	-$4K	–	1409
2014 Q4	$4K	Hold	3,000	–	–	﹤0.01%	1179
2014 Q3	$5K	Hold	3,000	–	–	﹤0.01%	1133
2014 Q2	$10K	Hold	3,000	–	–	﹤0.01%	1031
2014 Q1	$11K	Buy	+3,000	New	+$20.4K	﹤0.01%	1022

Other funds holding EXEL

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FineMark National Bank & Trust's EXEL Position: Q1 2015 in Review

FineMark National Bank & Trust sold out of Exelixis (EXEL) in Q1 2015, closing a stake of 3,000 shares — an estimated $4K sold.

FineMark National Bank & Trust first reported a position in EXEL in Q1 2014 and held it in 4 quarters. The position peaked at $11K in Q1 2014. 116 funds tracked by Wall St. Rank hold EXEL as of Q1 2015.

FineMark National Bank & Trust reported no remaining Exelixis position as of Q1 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 3,000 Exelixis shares in Q1 2015, an estimated $4K.
FineMark National Bank & Trust first reported a position in Exelixis in Q1 2014 and held it in 4 quarters.
FineMark National Bank & Trust's Exelixis position peaked at $11K in Q1 2014.
116 funds tracked by Wall St. Rank held Exelixis as of Q1 2015.

Based on FineMark National Bank & Trust's 13F filing for Q1 2015, filed 13 May 2015.